Ovarian Cancer Diagnostic Marker, Urteste S.A

← USPTO Patent Applications

COMPOUND - DIAGNOSTIC MARKER FOR OVARIAN CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF OVARIAN CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF OVARIAN CANCER

Application US20260098058A1 Kind: A1 Apr 09, 2026

Assignee

Urteste S.A.

Inventors

Adam LESNER, Natalia GRUBA

Abstract

The invention relates to a novel chemical compound—a diagnostic marker—for use in medicine, more specifically in cancer diagnosis, in particular the diagnosis of ovarian cancer. The invention also relates to an in vitro method for detecting enzymatic activity present in a subject's body fluid, in particular derived from ovarian cancer cells, using the compound. The invention further relates to an in vitro method for diagnosing ovarian cancer using the compound, a kit comprising the compound and use of the compound for the detection of enzymatic activity specific to ovarian cancer and use of the compound for the diagnosis of ovarian cancer. The invention also relates to the compound for use as a diagnostic marker of ovarian cancer and a method for the treatment of ovarian cancer comprising a step of carrying out the method for the diagnosis of ovarian cancer as defined above using the compound.

CPC Classifications

C07K 5/1021 C12Q 1/37 G01N 21/6428 G01N 2021/6439

Filing Date

2023-09-27

Application No.

19115290

View original document →